
A New Dawn for Diabetes Management: ReCET Combined with Semaglutide Offers Insulin Independence
Summary A groundbreaking study reveals a novel treatment strategy combining the ReCET procedure with semaglutide, eliminating insulin therapy for 86% of type 2 diabetes patients. This innovative approach offers a potential solution to the challenges […]